IMA
IMA
NASDAQ · Pharmaceuticals

Imagenebio Inc

$5.77
+0.06 (+1.05%)
As of Aug 8, 2:16 AM ET ·
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Buy 5 71%
Hold 1 14%
Sell 1 14%
Price Target
Analyst Price Target +108.3% upside
Low Target $8.98
Average Target $12.02
High Target $15.27
Current Price $5.77
Current
$5.77
Target
$12.02
$8.98 $12.02 avg $15.27
Scenario Analysis
Bear Case
$8.98
55.6%
Low target
Base Case
$12.02
+108.3%
Avg target
Bull Case
$15.27
+164.6%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$16.47
-65.0% from high
52-Week Low
$3.94
+46.4% from low
Target vs 52W High
$12.02
-27.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%